ReviewClinical pharmacokinetics2022

Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect.

Gera Narendra et al.PubMed ↗Publisher ↗

No numbers read from the abstract.